基于碎片分子轨道方法的结合性自由能量计算及其在设计新型SHP-2体抑制剂中的应用
Zhen Yuan1, Xingyu Chen1, Sisi Fan1
1Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science & Technology, Shanghai 200237, China.
International journal of molecular sciences
|January 11, 2024
概括
一种新的量子力学方法,FMOScore,通过包括溶解和变形能量,准确地预测结合的自由能量. 这种方法通过改善联体蛋白结合亲和性预测来增强药物设计,并导致发现了一种新型SHP-2抑制剂.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 结构生物学是结构生物学.
背景情况:
- 准确预测结合的自由能量对于基于结构的药物设计至关重要.
- 量子力学 (QM) 方法提供了高精度,但面临着计算方面的挑战.
- 碎片分子轨道 (FMO) 方法降低了QM计算成本,但需要用于结合亲和力预测的增强.
研究的目的:
- 开发一种改进的基于QM的方法,用于预测连接物-蛋白结合的自由能量.
- 通过结合额外的能量项来增强碎片分子轨道 (FMO) 方法.
- 为了验证新方法的性能与既有预测技术相比.
主要方法:
- 开发了FMOScore,一种基于QM的具有约束力的自由能量计算方法.
- 将气相潜在能量,变形能量和溶解自由能量纳入线性合适模型中.
- 评估隐式溶剂方法以提高FMO性能.
- 将FMOScore预测与FEP+,MM/PBSA,MM/GBSA和Autodock vina进行了比较.
主要成果:
- 与传统方法相比,FMOScore显示出良好的预测准确度.
- 包括溶解自由能量和变形能量计算在内,提高了FMO对结合亲和力的精度.
- 一个回顾性案例研究证实了增强的预测能力.
- 在FMOScore指导的优化中,发现了一种新且强效的全性SHP-2抑制剂 (化合物8).
结论:
- 在药物设计中,FMOScore提供了一个更准确和计算可行的方法来预测结合的自由能量.
- 纳入溶解和变形能量对于改进基于QM的结合亲和力预测至关重要.
- 开发的方法有助于有效的药物发现,正如新的SHP-2抑制剂的识别所证明的那样.
相关概念视频
Molecular Orbital Theory II
19.2K
Molecular Orbital Energy Diagrams
19.2K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
MO Theory and Covalent Bonding
10.5K
The molecular orbital theory describes the distribution of electrons in molecules in a manner similar to the distribution of electrons in atomic orbitals. The region of space in which a valence electron in a molecule is likely to be found is called a molecular orbital. Mathematically, the linear combination of atomic orbitals (LCAO) generates molecular orbitals. Combinations of in-phase atomic orbital wave functions result in regions with a high probability of electron density, while...
10.5K
Molecular Orbital Theory I
32.1K
Overview of Molecular Orbital Theory
32.1K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Cooperative Allosteric Transitions
2.3K
2.3K


